Barbadin is a novel and selective β-arrestin/β2-adaptin interaction inhibitor. It has IC50 values of 19.1 μM for β-arrestin1 and 15.6 μM for β-arrestin2. Barbadin blocks agonist-promoted endocytosis of the prototypical β2-adrenergic, V2-vasopressin and angiotensin-II type-1 receptors[1].

356568-70-2

C19H15N3OS

333.41

DMSO:50 mg/mL (149.97 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years